News & Events

Pfizer Securities Litigation

On 27 January 2015, parties in the Pfizer securities litigation reached an agreement to settle the case for $400 million. CFR provided analyses of market efficiency, loss causation, and damages for the case.

AIG Securities Litigation

On 4 August 2014, parties in the American International Group 2008 Securities Litigation agreed to a settlement of $970.5 million. CFR provided analysis of market efficiency for the case.

Blackstone Securities Litigation

On 29 August 2013, The New York Times reported that parties in the Blackstone securities litigation agreed to a settlement. CFR provided analysis of loss causation and damages for the case.

Longtop Financial Technologies Jury Verdict

On 20 and 24 November 2014, Professor Steven Feinstein of Babson College and Crowninshield Financial Research testified in Federal Court in the Longtop Financial Technologies securities class action lawsuit.

Idearc Securities Litigation

On June 10, 2013, parties in the Idearc, Inc. securities litigation agreed to a settlement. CFR provided analyses of market efficiency, loss causation, and damages for the case.

Merrill Lynch & Co. Inc. Securities Litigation

On August 29, 2012, a New Jersey court denied Merrill Lynch & Co. Inc.’s motion for summary judgment over a pension fund’s $300 million investment in preferred stock.

Auditor Signature P. Smith

If the Auditors Sign Off, Does That Make It Okay?

Lawrence A. Weiss, an Accounting Expert with Crowninshield, published an article in the Harvard Business Review regarding the role of auditors in the case of Enron. Professor Weiss discusses regulation and prevention of fraud in class action securities cases.

Market Signals Of Investment Unsuitability

by Steven P. Feinstein, Ph.D., CFA, Alexander Liss and Steven Achatz, Crowninshield Financial Research LLC As published in Law360 To read the full article, please …